Alto Neuroscience

ANRO • NYSE • Stock Fundamentals

Alto Neuroscience is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Amit Etkin, with a market cap of $739.1M.

Market Cap$739.1M

Employees63.0

CEOAmit Etkin

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Alto Neuroscience

Alto Neuroscience (ANRO) has a market capitalization of $739.1M and trades on NYSE.

Alto Neuroscience has approximately 63 employees.